Syngen Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	2,136	2,014	1,837	1,931	1,471
Revenue Growth (YoY)	6.10%	9.60%	-4.84%	31.22%	12.19%
Cost of Revenue	1,413	1,290	1,193	1,242	942.93
Gross Profit	723.59	723.94	643.92	688.15	528.34
Selling, General & Admin	339.07	354.38	302.88	262.63	197.02
Research & Development	60.56	59.34	46.76	45.32	49.52
Operating Expenses	396.61	420.64	341.06	325.78	246.86
Operating Income	326.98	303.3	302.86	362.38	281.48
Interest Expense	-5.65	-9.28	-8.86	-5.07	-3.21
Interest & Investment Income	2.38	2.05	1.43	0.61	0.32
Earnings From Equity Investments	8.09	-5.32	36.08	26.64	14.81
Currency Exchange Gain (Loss)	-	5.32	-1.93	10.29	-4.31
Other Non Operating Income (Expenses)	3.05	4.18	4.49	1.58	7.87
EBT Excluding Unusual Items	334.84	300.25	334.07	396.42	296.95
Gain (Loss) on Sale of Investments	-	-0.49	0.02	0.21	0.98
Gain (Loss) on Sale of Assets	-	-0.15	-0.28	-0.21	-0.63
Asset Writedown	-	-	-	-	-1.81
Pretax Income	334.84	299.61	333.8	396.42	295.49
Income Tax Expense	63.25	59.4	58.98	75.18	57.72
Net Income	271.59	240.21	274.83	321.24	237.77
Net Income to Common	271.59	240.21	274.83	321.24	237.77
Net Income Growth	13.07%	-12.60%	-14.45%	35.10%	10.31%
Shares Outstanding (Basic)	27	27	27	27	27
Shares Outstanding (Diluted)	27	27	27	27	27
Shares Change (YoY)	0.01%	-	-0.01%	-0.00%	-0.01%
EPS (Basic)	10.02	8.86	10.14	11.85	8.77
EPS (Diluted)	10.01	8.85	10.13	11.84	8.76
EPS Growth	13.11%	-12.64%	-14.44%	35.16%	10.33%
Free Cash Flow	255.92	287.83	323.23	-306.79	274.83
Free Cash Flow Per Share	9.43	10.61	11.91	-11.31	10.13
Dividend Per Share	-	5.000	5.000	5.000	4.000
Dividend Growth	-	-	-	25.00%	14.29%
Gross Margin	33.87%	35.95%	35.05%	35.64%	35.91%
Operating Margin	15.30%	15.06%	16.48%	18.77%	19.13%
Profit Margin	12.71%	11.93%	14.96%	16.64%	16.16%
Free Cash Flow Margin	11.98%	14.29%	17.59%	-15.89%	18.68%
EBITDA	448.31	402.1	386.21	432.93	347.82
EBITDA Margin	20.98%	19.97%	21.02%	22.43%	23.64%
D&A For EBITDA	121.33	98.8	83.35	70.56	66.34
EBIT	326.98	303.3	302.86	362.38	281.48
EBIT Margin	15.30%	15.06%	16.48%	18.77%	19.13%
Effective Tax Rate	18.89%	19.83%	17.67%	18.96%	19.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.